BridgeMD
New treatment option for Osteoarthritis
Official title Intra-articular Corticosteroid With Hyaluronic Acid Plus Physiotherapy for Hip Pathologies (NON-OP HIP)
ClinicalTrials.gov ID: NCT06653985
What this study is testing
What is Hyaluronic and corticosteroid injection?
Hyaluronic and corticosteroid injection is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for osteoarthritis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Hip pathologies that cause pain and functional limitations are common in the general population. These can include femoroacetabular impingement (FAI), labral tears and mild osteoarthritis (OA) among others.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 60
You may be able to join if
- Patients aged 40-60 years old.
- Patients with mild hip arthritis (Kellgren-Lawrence grade 2 or lower) with or without a labral tear and/or femoroacetabular impingement and/or mild...
- Patients who demonstrate more than 50% reduction in hip pain following a diagnostic injection (ultrasound guided intra-articular anaesthetic only).
- Able to subsidize private physiotherapy services.
- Able to provide informed consent.
You likely can't join if
- Active infection
- Osteonecrosis of the hip, moderate to severe arthritis (Kellgren-Lawrence grade 3 or higher), or moderate-to-severe hip dysplasia
- Previous hip fracture, pelvic fracture, or lower limb fracture,
- Previous surgery to the pelvis, hip or lower limb
- Hypermobility disorder or connective tissue disease (e.g. Ehler's-Danlos syndrome, Marfan's syndrome etc.)
- Patients with chronic low back pain and/or sciatica
See the full eligibility criteria
- Patients aged 40-60 years old.
- Patients with mild hip arthritis (Kellgren-Lawrence grade 2 or lower) with or without a labral tear and/or femoroacetabular impingement and/or mild hip dysplasia.
- Patients who demonstrate more than 50% reduction in hip pain following a diagnostic injection (ultrasound guided intra-articular anaesthetic only).
- Able to subsidize private physiotherapy services.
- Able to provide informed consent.
- Active infection
- Osteonecrosis of the hip, moderate to severe arthritis (Kellgren-Lawrence grade 3 or higher), or moderate-to-severe hip dysplasia
- Previous hip fracture, pelvic fracture, or lower limb fracture,
- Previous surgery to the pelvis, hip or lower limb
- Hypermobility disorder or connective tissue disease (e.g. Ehler's-Danlos syndrome, Marfan's syndrome etc.)
- Patients with chronic low back pain and/or sciatica
- Patients who received an intra-articular steroid hip injection within 3 months
- Patients who have previously received a hyaluronic acid injection
- Injuries sustained in a motor vehicle collision.
- Injuries sustained in the workplace and have a worker's compensation claim.
- Injuries resulting in a medico-legal dispute.
- Patients who are pregnant of planning to become pregnant
- Currently enrolled in a study that does not permit co-enrollment
- Unable to obtain informed consent
- Unable to comply with the study protocol
- Contraindication to corticosteroid or hyaluronic acid injection
- Prior enrollment in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Hamilton, Ontario, Canada
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hamilton, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.